Myelofibrosis Treatment in Faridabad

Myelofibrosis is a rare blood cancer that affects the bone marrow and its ability to produce healthy blood cells. It belongs to a group of blood disorders called myeloproliferative neoplasms (MPNs). As the condition progresses, scar tissue can develop in the bone marrow, affecting normal blood cell production and sometimes causing complications such as anaemia and an enlarged spleen.

A diagnosis of myelofibrosis can be difficult for patients and their families to understand. Knowing the condition, recognising its symptoms and discussing suitable treatment options with an experienced medical oncologist can help patients make informed decisions about their care.

Dr. Abhishek Bansal provides medical oncology consultations for blood cancers and related conditions. Patients seeking evaluation for myelofibrosis can discuss their symptoms, diagnostic reports and individual treatment needs with a specialist.

What Is Myelofibrosis?

Myelofibrosis is a type of chronic myeloproliferative neoplasm in which abnormal blood-forming cells contribute to the development of fibrosis, or scar tissue, in the bone marrow. This can interfere with the body’s ability to produce adequate numbers of healthy red blood cells, white blood cells and platelets.

The condition may occur as primary myelofibrosis or develop following another myeloproliferative neoplasm, such as polycythaemia vera or essential thrombocythaemia.

The progression of myelofibrosis varies between individuals. Some patients experience few symptoms initially, while others may develop anaemia, fatigue, abdominal discomfort or other complications that require medical attention.

Diagnosis of Myelofibrosis

Accurate diagnosis is an important part of myelofibrosis management. A medical oncologist may review the patient’s medical history, symptoms, previous blood reports and other clinical findings before recommending further investigations.

Complete Blood Count and Blood Smear
Blood tests help assess red blood cells, white blood cells and platelets. A peripheral blood smear may reveal changes that require further investigation.
Bone Marrow Biopsy
A bone marrow biopsy helps assess the appearance of blood-forming cells and the presence of fibrosis. It may be an important part of confirming the diagnosis.
Molecular Testing
Testing for mutations such as JAK2, CALR and MPL may help establish the diagnosis and characterise the disease.
Risk Assessment
The specialist evaluates relevant clinical and laboratory findings to understand disease risk and determine whether active treatment or regular monitoring is appropriate. Not every patient requires the same investigations. The diagnostic plan depends on the clinical situation.

Common Symptoms of Myelofibrosis

Recognising possible symptoms can help patients seek timely medical evaluation. Common symptoms of myelofibrosis include:

Persistent fatigue: Feeling unusually tired or weak, even after adequate rest.
Anaemia: Low red blood cell levels that may cause weakness, dizziness or breathlessness.
Enlarged spleen: Discomfort or a feeling of fullness in the upper-left abdomen.
Early satiety: Feeling full after eating only a small amount of food.
Night sweats and fever: Unexplained sweating during sleep or recurrent fever.
Unintentional weight loss: Losing weight without a clear explanation.
Bone pain or discomfort: Pain that may occur in some patients.

These symptoms can also be associated with other health conditions. A medical assessment is necessary to determine their cause.

Myelofibrosis Treatment Options

The treatment of myelofibrosis depends on the patient’s symptoms, disease risk, blood counts, overall health and treatment goals. The aim is to manage symptoms, address complications and monitor the condition appropriately.